The NMC Has Banned Remote Botox Prescribing. Here Is What That Means for You.

From 1 June 2025, the NMC has mandated that all nursing and midwifery prescribers must conduct face-to-face consultations before issuing prescriptions for non-surgical cosmetic procedures. Let me walk you through what changed, why it matters, and what it means for you as a patient navigating aesthetic medicine in the UK.

Face-to-Face Prescribing Rule (NMC – From 1 June 2025)

Area	What the Rule Says
Core requirement	Face-to-face consultation must occur before prescribing cosmetic POMs
Applies to	Nurse & midwife prescribers (NMC registered)
Not allowed	Prescribing via phone, video, or online without prior in-person exam
Medicines included	Botulinum toxin, dermal fillers (prescription components), hyaluronidase, injectable local anaesthetics
Scope	Non-surgical cosmetic procedures only
Regulatory status	Mandatory professional standard (fitness-to-practise relevant)

What the NMC actually said

The NMC's language is unambiguous. Nurse and midwife prescribers must not prescribe botulinum toxin, injected local anaesthetic, dermal fillers, hyaluronidase, or other prescription-only medicines for cosmetic use by telephone, video link, or online, for patients they have not personally examined face-to-face.

Not discouraged. Not less than ideal. Not permitted.

This covers the full range of prescription-only medicines used routinely in aesthetic practice: botulinum toxin (including Botox, Azzalure, and Bocouture), prescription-strength topical anaesthetics, and emergency aesthetic medicines including hyaluronidase, the enzyme used to dissolve filler in vascular emergencies.

The JCCP reinforced this position with equally direct language, confirming that face-to-face clinical assessment is a central requirement for patient safety and public protection. When two major regulatory bodies speak in unison and without hedging, the sector needs to listen.

What drove this? Research, primarily. In 2024 the NMC commissioned independent public-facing research and found that many people who had undergone cosmetic procedures had no idea the medicines involved were prescription-only. They had not thought to ask how those medicines were obtained. They described the sector as overly accessible, patchy in its training standards, and difficult to navigate safely. That evidence became the foundation of the new position.

This is not a sudden regulatory overreaction. The GMC prohibited remote prescribing of botulinum toxin for aesthetic use back in 2012. The General Dental Council and General Pharmaceutical Council followed. The NMC's June 2025 mandate finally brings nursing prescribers into alignment with the standards every other regulated healthcare profession in aesthetics has long been held to.

Why face-to-face assessment is not negotiable

Let me explain exactly what I am doing when I assess a patient before treatment. Because this is not bureaucracy. This is clinical medicine, and every step has a reason.

Clinical Risks Reduced by Face-to-Face Assessment

Risk Area	What Can Be Missed Remotely
Vascular complications	Inaccurate injection planning increases occlusion risk
Allergic reactions	Incomplete history for anaesthetics or fillers
Neurological conditions	Facial asymmetries or underlying pathology
Infection risk	Skin conditions not visible in low-resolution video
Poor aesthetic outcome	Misjudged muscle strength or anatomy

I start by watching your face move. Not through a screen where compression algorithms flatten three-dimensional anatomy and domestic lighting wipes out the subtle asymmetries that determine injection placement. I watch you smile, frown, raise your brows, squint. I am mapping dynamic muscle activity patterns. Where does your frontalis engage unevenly? How strongly do your corrugator muscles contract when you concentrate? Does your orbicularis oculi have different resting tone on each side? These details are not decorative. They determine injection sites, dosing, and the difference between a balanced result and one that makes someone look permanently surprised.

Then I use my hands.

I palpate your facial tissues. My fingers read skin thickness, the quality of the dermis, the tone of underlying muscle, the presence of scar tissue from old treatments or injuries you may have forgotten about. This tactile information shapes injection depth and technique in ways that no video call can replicate. You simply cannot palpate through a screen.

After that, I map your vascular anatomy. My years in cardiac nursing gave me a particular respect for vasculature, and I bring that directly into the treatment room. The temporal artery. The supratrochlear and supraorbital vessels. The angular artery near the nose, which sits deceptively close to common injection sites for anti-wrinkle treatment and dermal fillers. These structures matter enormously in areas like the glabella, the forehead, and the nasolabial folds. Anatomically speaking, the glabellar region carries one of the highest vascular risk profiles of any area in facial aesthetics. I need to see it. Not a photograph of it.

Medical history comes next, and this is where in-person assessment reveals things that video calls routinely miss. I probe. When a patient seems vague about a medication they're taking, I press gently. When someone's non-verbal responses suggest anxiety or expectations that don't quite match what treatment can realistically deliver, I pick that up. I look for contraindications that require direct observation: active skin infections, signs of neuromuscular conditions, asymmetries that might suggest something neurological worth investigating before we proceed.

This assessment takes time. It requires presence. It cannot happen remotely. It never could.

Medicines Covered Under the Rule

Category	Examples
Neuromodulators	Botox, Azzalure, Bocouture
Dermal fillers (POM-related use)	Hyaluronic acid fillers requiring prescription governance
Emergency reversal agents	Hyaluronidase
Anaesthetics	Prescription-strength topical/injectable local anaesthetics

What the evidence tells us

The NMC did not arrive at this position arbitrarily. They commissioned research, engaged stakeholders across the sector, and concluded that face-to-face assessment meaningfully improves the quality of prescribing decisions for injectable aesthetic medicines.

From a pure clinical logic standpoint, the case is not complicated. Remote assessment for procedures involving prescription neurotoxins requires a practitioner to determine dosing, placement, and contraindications from a fundamentally incomplete clinical picture. A video call, a photograph, a patient-completed form: none of these provide the three-dimensional structural information that direct examination does.

This is backed by research beyond the NMC's own. Studies on remote versus in-person assessment in dermatology consistently find that face-to-face encounters yield more complete clinical information, particularly where structural evaluation is needed. A 2025 systematic review in the British Journal of Dermatology found that teledermatology offers only moderate diagnostic accuracy for complex assessments and specifically noted that conditions requiring structural evaluation benefit most from direct contact. The implications for injectable aesthetics, where structural assessment is not incidental but central to prescribing safety, are obvious.

There is also the question of the therapeutic relationship, and this matters more than clinical documentation sometimes acknowledges. When I meet you in person, assess your face, explain what I am seeing and why it shapes my approach, I am building the foundation of trust that improves actual treatment outcomes. Patients who receive thorough in-person consultations have more realistic expectations, communicate concerns more openly, and report fewer adverse events. Remote prescribing dismantles that foundation before the first appointment has even begun.

The risks that tend not to be discussed

There is one aspect of this regulation I want to address directly, because it does not get enough attention.

Prescription-only topical anaesthetics are used routinely before painful aesthetic procedures, and they were among the medicines being prescribed remotely at an alarming rate. These are not innocuous substances. They carry genuine risks: allergic reactions ranging from contact dermatitis to anaphylaxis, systemic absorption with potential cardiac effects including arrhythmia, and methaemoglobinaemia in susceptible individuals, a condition where haemoglobin loses its ability to carry oxygen effectively.

My cardiac background means those risks are not abstract to me. They are mechanisms I understand viscerally. Prescribing these medications without examination, without a proper allergy and medical history review, without any assessment of the patient in front of you, is indefensible. The new regulations close that gap.

For repeat treatments, the guidance allows some clinical flexibility where an established relationship exists. But here is what patients need to hear clearly: circumstances change. New medications appear. Health conditions develop. Muscle activity patterns shift with age. A practitioner who truly understands these dynamics insists on regular face-to-face reviews regardless of how long they have known you.

What Proper Consultation Should Include

Component	Standard
Medical history	Full, structured review
Physical exam	Face-to-face facial assessment
Risk explanation	Procedure-specific and anatomy-specific
Outcome planning	Realistic, individualised goals
Consent	Written informed consent
Treatment environment	Registered clinical setting
Emergency readiness	Hyaluronidase and protocols available

The broader picture

The NMC's position does not exist in isolation. The UK government's work on licensing non-surgical cosmetic procedures in England attracted nearly 12,000 consultation responses and is moving toward a framework that will require high-risk procedures to be performed only by qualified healthcare professionals in properly registered facilities. Local authority licensing will extend to botulinum toxin. Practitioners will need to demonstrate rigorous safety standards, training credentials, and appropriate insurance.

Remote prescribing will not survive in that environment. It cannot meet the standards the framework demands.

What this regulatory convergence represents, taken together, is a long-overdue normalisation: aesthetic medicine being treated with the same professional seriousness applied to every other area of clinical practice. That should have happened sooner. The fact that it is happening now is still worth welcoming.

What patients should demand

If you are considering anti-wrinkle injections, dermal fillers, or any injectable aesthetic treatment, here is what proper practice looks like. Insist on all of it.

A thorough face-to-face consultation before any prescription or treatment. This means a full medical history, direct examination of your facial anatomy and dynamic muscle activity, an honest conversation about realistic outcomes, and clear explanation of the risks specific to your anatomy and medical history. If a practitioner offers to prescribe based on photos or a video call, that is a red flag significant enough to walk away from.

Verification of credentials. Ask for the practitioner's NMC, GMC, or GPhC registration number, depending on their profession. Look it up yourself at nmc.org.uk or jccp.org.uk. Any practitioner who hesitates when you ask for this is telling you something important. You can read more about what credentials matter and why on our About page.

A proper clinical setting. Not a home treatment room, not a hotel suite, not a pop-up at a shopping centre. A registered facility with appropriate emergency equipment, written protocols, and the immediate capacity to manage complications. Hyaluronidase on site, for instance, is non-negotiable where fillers are being administered.

Time. Ethical practitioners do not rush consultations. They want you to leave with a clear, accurate understanding of what you are consenting to. Pressure to book immediately is a warning sign.

Written consent. Documented evidence that you understand the treatment, the risks, and the alternatives. This is not bureaucracy either. It is the minimum standard of informed consent.

When remote prescribing goes wrong

I have seen the consequences in my clinic. Patients arriving after treatment elsewhere, having been assessed by someone they only ever encountered on a screen, with complications that proper examination would likely have prevented.

Infections requiring antibiotics or surgical drainage. Vascular compromise needing immediate intervention. Asymmetry from dosing decisions made without accurate muscle mapping. Allergic reactions to anaesthetic preparations that were prescribed without any allergy history taken in person.

The psychological impact often outlasts the physical complications. Patients lose confidence in their appearance, develop distrust of aesthetic medicine generally, and sometimes present with features consistent with body dysmorphic disorder. When treatments are prescribed by practitioners who never established a proper clinical relationship, there is no relationship to fall back on when things go wrong. Patients have nowhere to turn.

These complications also carry a cost to the NHS. Time in A&E. Surgical interventions. Dermatology and plastics referrals. Proper prescribing standards prevent this burden by addressing the risk before it becomes a crisis.

Why I welcome this

As someone registered with the NMC, verified by the JCCP, and a member of the British Association of Cosmetic Nurses, I have found remote prescribing professionally troubling since the moment it became commonplace. These regulations do not change how I practice. They simply make explicit what I have always believed: that aesthetic treatments are medical procedures, and medical procedures require medical standards.

When I explain to patients why I will not accept prescriptions issued remotely, I use a comparison they understand immediately. Would you trust a cardiologist who prescribed antihypertensives without examining you? Would you feel comfortable accepting a statin prescription from someone who had never listened to your heart, checked your blood pressure, or reviewed your full lipid panel in person? Of course not. The pharmaceutical mechanism of botulinum toxin is no less serious for being used cosmetically. It temporarily paralyses muscles. It requires the same prescribing rigour as any other prescription-only medicine that alters physiological function.

These regulations validate what conscientious practitioners have maintained for years. Proper prescribing requires proper assessment. Proper assessment requires face-to-face consultation. That is not restrictive regulation. That is medicine practised with integrity.

In my cardiac days, I learned that cutting corners costs patients their health. The principle has not changed. Only the context has.

Your next steps

Choose a practitioner who insists on meeting you in person before any prescription or treatment. Ask about their qualifications, their NMC registration number, their experience with the specific treatment you are considering. A practitioner who welcomes these questions is a practitioner who prioritises your safety.

If you have been prescribed Botox remotely in the past, that chapter has now closed. Future treatments require proper face-to-face assessment from a qualified, registered prescriber.

If a practitioner offers remote prescribing after 1 June 2025, you can report them to the NMC. This is not punitive. It is about preventing the same harm from reaching the next patient.

Frequently asked questions

Is remote Botox prescribing now illegal in the UK?

From 1 June 2025, the NMC requires all nurse and midwife prescribers to conduct face-to-face consultations before prescribing prescription-only medicines for cosmetic use. This is a binding professional standard. Breaching it is a fitness-to-practise matter that can result in a practitioner losing their registration. The GMC has held the same position since 2012.

What should a proper Botox consultation include?

A full medical history. Direct physical examination of your facial anatomy and dynamic muscle activity. An honest discussion of realistic outcomes and potential risks specific to your anatomy. Written consent. The consultation should not feel rushed. Measurements or marking of injection points before treatment begins is a marker of careful, considered practice.

Does this affect repeat patients with an established prescriber?

The NMC's position applies to initial prescribing and to ongoing prescriptions where anything relevant may have changed. Health conditions evolve. Medications change. Muscle activity shifts with age. Good practitioners conduct face-to-face reassessments for all patients, established or new, before each treatment course.

What happens if a prescriber continues prescribing remotely?

It constitutes a breach of NMC standards and a fitness-to-practise matter. Patients can report concerns directly to the NMC. Practitioners risk suspension or removal from the register.

How do I verify a practitioner's credentials?

Check NMC registration at nmc.org.uk, GMC registration at the GMC website, and JCCP verification at jccp.org.uk. Ask any practitioner for their registration number and verify it yourself. Any practitioner who is reluctant to provide this is worth reconsidering.

References

1. Nursing and Midwifery Council. NMC to update position on remote prescribing of non-surgical cosmetic medicines. nmc.org.uk

2. Joint Council for Cosmetic Practitioners. NMC launches updated guidance that embargos remote prescribing for elective non-surgical cosmetic procedures. jccp.org.uk

3. UK Government. The licensing of non-surgical cosmetic procedures in England: consultation response. gov.uk

4. MHRA. MHRA crackdown on illegal Botox after victims left seriously ill. gov.uk